Otto Mayer
-
- Blood Pressure and Hypertension Studies 30
- Cardiovascular Health and Disease Prevention 19
- Cardiac Health and Mental Health 13
- Heart Failure Treatment and Management 8
- Nephrology top 5%
- Nutrition and Dietetics top 5%
- Rheumatology top 5%
- Folate and B Vitamins Research 13
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
-
- Lipoproteins and Cardiovascular Health 15
-
- Acute Ischemic Stroke Management 10
- Co-authors
- Renata CífkováHana RosolováJan FilipovskýJitka SeidlerováPeter WohlfahrtJan BruthansJiří VaněkGerald M. Reaven
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Otto Mayer
140 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 140
- Cardiology and Cardiovascular Medicine 608
- Nephrology 161
- Nutrition and Dietetics 308
- Rheumatology 248
- Endocrinology, Diabetes and Metabolism 232
Countries citing papers authored by Otto Mayer
This map shows the geographic impact of Otto Mayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otto Mayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otto Mayer more than expected).
Fields of papers citing papers by Otto Mayer
This network shows the impact of papers produced by Otto Mayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otto Mayer. The network helps show where Otto Mayer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Otto Mayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2020 | 8 | |
| 4 | 2020 | 18 | |
| 5 | 2020 | 31 | |
| 6 | 2019 | 10 | |
| 7 | 2018 | 2 | |
| 8 | 2017 | 15 | |
| 9 | 2015 | 41 | |
| 10 | 2015 | 4 | |
| 11 | 2015 | 24 | |
| 12 | 2014 | 10 | |
| 13 | 2014 | 8 | |
| 14 | 2014 | 3 | |
| 15 | 2013 | 34 | |
| 16 | 2011 | 1 | |
| 17 | 2008 | 9 | |
| 18 | Otto Mayer : Studien zu den geistigen Grundlagen seiner Verwaltungsrechtswissenschaft | 1981 | 1 |
| 19 | [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)]. | 1976 | 1 |
| 20 | 1972 | 20 |
About Otto Mayer
Otto Mayer is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Endocrinology, Diabetes and Metabolism, Rheumatology and Nutrition and Dietetics, having authored 146 papers that have together received 1.8k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (30 papers), Cardiovascular Health and Disease Prevention (19 papers), Lipoproteins and Cardiovascular Health (15 papers), Folate and B Vitamins Research (13 papers), Cardiac Health and Mental Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Acute Ischemic Stroke Management (10 papers) and Heart Failure Treatment and Management (8 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (608 citations), Nephrology (161 citations), Nutrition and Dietetics (308 citations), Rheumatology (248 citations) and Endocrinology, Diabetes and Metabolism (232 citations). Otto Mayer has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Renata Cífková, Hana Rosolová, Jan Filipovský, Jitka Seidlerová, Peter Wohlfahrt, Jan Bruthans, Jiří Vaněk, Gerald M. Reaven, Alena Krajčoviechová and Jaroslav Šimon. Their work appears in journals such as Journal of Hypertension, Atherosclerosis, Blood Pressure, Physiological Research and Journal of Human Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.